The Global Core Biopsy Needles Market Size Is Projected To Grow At A CAGR Of 5.5% During The Forecast Period 2022-2030.

Core Biopsy Needles Market Overview:

A biopsy is a surgical procedure in which tissue is removed from an organ to determine the presence or extent of disease. Surgeons, radiologists, and interventional cardiologists are the most common people who do this. Biopsies of body organs such as lungs, liver, and kidneys are performed using a biopsy device. A biopsy needle is a device specifically designed to remove small amounts of tissue from the body for diagnostic testing. Biopsy procedures are done for a variety of reasons: to examine a lump or mass, to determine whether a suspicious area is cancerous or benign, or to evaluate an organ for transplant.

Core Biopsy Needles market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Core Biopsy Needles market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Major Market Segments Covered in Core Biopsy Needles Industry Research:

Market Key Players:
BD, Hologic, Inc., Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, INVIVO THERAPEUTICS, MDL SRL., STERYLAB S.r.l., UROMED Kurt Drews KG, BPB medica, Koninklijke Philips N.V., Medtronic, GENERAL ELECTRIC COMPANY, Leica Biosystems Nussloch GmbH, ZAMAR CARE., Stryker, Messe Düsseldorf GmbH, Kompass, COMPASS International Innovations, Inc., HAKKO CO.,LTD. and Cardinal Health

Industry News:

• In February 2022, Argon Medical Devices announced the acquisition of Achieve Medical, a manufacturer of biopsy needles and biopsy kits. This acquisition is expected to expand Argon's product portfolio in the biopsy market.
• In January 2022, Medtronic plc received clearance from the US Food and Drug Administration (FDA) for a core biopsy system designed to take tissue samples from breast, lung and soft tissue.
• In November 2021, Becton, Dickinson and Company (BD) announced the release of a new BD MAXcore biopsy device. This product is designed to improve the speed and accuracy of breast biopsies.
• In August 2021, Merit Medical Systems announced the acquisition of Brightwater Medical, a developer of medical devices for the treatment of chronic obstructive pulmonary disease (COPD) and other lung diseases, including biopsy needles.

By Type:

• Full- automated core needle biopsy device
• Semi- automated core needle biopsy device

By Range:

• 14G- 18G
• <14G and >18G

By Disease:

• Lung Cancer
• Liver Cancer
• Breast Cancer
• Prostate Cancer
• Other

By Application:

• Hospitals
• Clinics
• Others

By Region:

One of the greatest markets for core biopsy needles is North America. This region's market is growing due to the high prevalence of cancer, a well-established healthcare infrastructure, and a large patient pool.
Europe is also a significant market for core biopsy instruments, propelled by the rising incidence of cancer, the aging population, and the availability of advanced healthcare infrastructure.
The Asia-Pacific region is anticipated to be the fastest-growing market for core biopsy instruments due to the region's rising cancer incidence, aging population, and rising healthcare costs. Increasing demand for minimally invasive biopsy procedures and adoption of advanced medical technologies also contribute to the growth of this region's market.
The Latin American market for core biopsy needles is expanding due to the rising prevalence of cancer and related diseases, the improvement of healthcare infrastructure, and the rising demand for diagnostic instruments.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Drivers:

Cancer is becoming more common: The number of people getting cancer is going up all over the world, so there is a lot more demand for core biopsy tools. Because biopsy processes are so important for figuring out what kind of cancer someone has and how far along it is, more and more people are using biopsy needles.
The introduction of minimally invasive biopsy procedures has made patients more comfortable, improved the accuracy of diagnoses, and cut down on the time it takes to get better. Imaging technology improvements, such as ultrasound and MRI, have also helped the market grow.
Growing demand for customized medicine: As the need for targeted therapies and personalized medicine grows, so does the importance of accurate diagnosis through tissue biopsy. Core biopsy needles are important for getting tissue samples for genetic testing, which can help make personalized treatment plans.

Restraints:

High cost: Core biopsy needles and the procedures that go with them are hard to get and can be hard to pay, especially in low-income countries where the cost of health care can be too high. This reduces the size of the market.
Stringent regulatory requirements: The requirements for the approval of biopsy needles can be strict and time-consuming, which can slow the rate of growth in the market. This can make it hard for companies to make new goods or improve the ones they already have.
Lack of skilled professionals: To do a biopsy, you need skilled professionals, which can slow the growth of the market, especially in places where there aren't enough trained doctors and nurses.

Opportunities:

Innovations in technology: The creation of new biopsy technologies that are more accurate, less invasive, and cheaper is a chance for the market to grow. New technologies, like 3D printing, can help make biopsy tools that are more accurate and work better.
new markets: The growth of the market in new economies gives businesses a lot of chances to grow. Demand for advanced medical equipment and healthcare services is growing in these countries because the middle class is growing and people are spending more money on healthcare.
Collaborations: Tissue biopsy processes can be more accurate and take less time if doctors, diagnostic companies, and companies that make medical devices work together. These partnerships can help come up with better ways to do biopsies and improve the level of care for patients.

Core Biopsy Needles Market report scope:

Key Takeaways from this Core Biopsy Needles Report

• Estimate Core Biopsy Needles market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the Core Biopsy Needles market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

What is the CAGR of Core Biopsy Needles market?

The Core Biopsy Needles Market is growing at a CAGR of 5.5% During Forecast Period.

What are the key types of Core Biopsy Needles market?

Full- automated core needle biopsy device, Semi- automated core needle biopsy device

What are the key applications of Core Biopsy Needles market?

Hospitals, Clinics, Others

Who are the key players in Core Biopsy Needles market?

BD, Hologic, Inc., Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, INVIVO THERAPEUTICS, MDL SRL., STERYLAB S.r.l., UROMED Kurt Drews KG, BPB medica, Koninklijke Philips N.V., Medtronic, GENERAL ELECTRIC COMPANY, Leica Biosystems Nussloch GmbH, ZAMAR CARE., Stryker, Messe Düsseldorf GmbH, Kompass, COMPASS International Innovations, Inc., HAKKO CO.,LTD. and Cardinal Health